1. Home
  2. SOAR vs QNRX Comparison

SOAR vs QNRX Comparison

Compare SOAR & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Volato Group Inc.

SOAR

Volato Group Inc.

HOLD

Current Price

$0.18

Market Cap

11.3M

Sector

Finance

ML Signal

HOLD

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$7.01

Market Cap

9.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOAR
QNRX
Founded
2021
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3M
9.2M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
SOAR
QNRX
Price
$0.18
$7.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.1M
901.9K
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
104.83
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$3.25
52 Week High
$4.36
$41.80

Technical Indicators

Market Signals
Indicator
SOAR
QNRX
Relative Strength Index (RSI) 49.16 63.74
Support Level $0.19 $6.27
Resistance Level $0.19 $8.25
Average True Range (ATR) 0.02 0.41
MACD -0.01 -0.04
Stochastic Oscillator 19.59 50.01

Price Performance

Historical Comparison
SOAR
QNRX

About SOAR Volato Group Inc.

Volato Group Inc is an aviation technology company that connects travelers to private, on-demand flight access and develops proprietary software platforms for enterprise and operational applications. The company operates in a single operating and reportable segment, private aviation services. It operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: